Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Impact of lipid nanoparticle size on mRNA vaccine immunogenicity
Kimberly J. Hassett, Jaclyn S. Higgins, Angela Woods, et al.
Journal of Controlled Release (2021) Vol. 335, pp. 237-246
Open Access | Times Cited: 234

Showing 1-25 of 234 citing articles:

The role of lipid components in lipid nanoparticles for vaccines and gene therapy
Camilla Hald Albertsen, Jayesh A. Kulkarni, Dominik Witzigmann, et al.
Advanced Drug Delivery Reviews (2022) Vol. 188, pp. 114416-114416
Open Access | Times Cited: 533
Chemistry of Lipid Nanoparticles for RNA Delivery
Yulia Eygeris, Mohit Gupta, Jeonghwan Kim, et al.
Accounts of Chemical Research (2021) Vol. 55, Iss. 1, pp. 2-12
Closed Access | Times Cited: 453
Microfluidic technologies and devices for lipid nanoparticle-based RNA delivery
Masatoshi Maeki, Shuya Uno, Ayuka Niwa, et al.
Journal of Controlled Release (2022) Vol. 344, pp. 80-96
Open Access | Times Cited: 181
Lyophilization provides long-term stability for a lipid nanoparticle-formulated, nucleoside-modified mRNA vaccine
Hiromi Muramatsu, Kieu Lam, Csaba Bajusz, et al.
Molecular Therapy (2022) Vol. 30, Iss. 5, pp. 1941-1951
Open Access | Times Cited: 167
Delivery Strategies for mRNA Vaccines
Sivakumar Ramachandran, Soumya Ranjan Satapathy, Tathagata Dutta
Pharmaceutical Medicine (2022) Vol. 36, Iss. 1, pp. 11-20
Open Access | Times Cited: 125
Biodistribution and Non-linear Gene Expression of mRNA LNPs Affected by Delivery Route and Particle Size
Jiaxing Di, Zhili Du, Kangzeng Wu, et al.
Pharmaceutical Research (2022) Vol. 39, Iss. 1, pp. 105-114
Open Access | Times Cited: 121
Recent advances in mRNA-LNP therapeutics: immunological and pharmacological aspects
Seyed Hossein Kiaie, Naime Majidi Zolbanin, Armin Ahmadi, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 118
Immunogenicity of lipid nanoparticles and its impact on the efficacy of mRNA vaccines and therapeutics
Yeji Lee, Michaela Jeong, Jeongeun Park, et al.
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 10, pp. 2085-2096
Open Access | Times Cited: 112
Lipid nanoparticles for delivery of RNA therapeutics: Current status and the role of in vivo imaging
Han Na Jung, Seok‐Yong Lee, Somin Lee, et al.
Theranostics (2022) Vol. 12, Iss. 17, pp. 7509-7531
Open Access | Times Cited: 109
Characterization of nanoparticles-based vaccines for COVID-19
Giuditta Guerrini, Davide Magrì, Sabrina Gioria, et al.
Nature Nanotechnology (2022) Vol. 17, Iss. 6, pp. 570-576
Open Access | Times Cited: 103
Lipid nanoparticles (LNPs) for in vivo RNA delivery and their breakthrough technology for future applications
Michaela Jeong, Yeji Lee, Jeongeun Park, et al.
Advanced Drug Delivery Reviews (2023) Vol. 200, pp. 114990-114990
Closed Access | Times Cited: 88
mRNA-LNP vaccines tuned for systemic immunization induce strong antitumor immunity by engaging splenic immune cells
Sanne Bevers, Sander A.A. Kooijmans, Elien Van de Velde, et al.
Molecular Therapy (2022) Vol. 30, Iss. 9, pp. 3078-3094
Open Access | Times Cited: 83
Quality by Design for enabling RNA platform production processes
Simon Daniel, Zoltán Kis, Cleo Kontoravdi, et al.
Trends in biotechnology (2022) Vol. 40, Iss. 10, pp. 1213-1228
Open Access | Times Cited: 73
Iterative Design of Ionizable Lipids for Intramuscular mRNA Delivery
Grayson Tilstra, Julien Couture‐Senécal, Yan Ming Anson Lau, et al.
Journal of the American Chemical Society (2023) Vol. 145, Iss. 4, pp. 2294-2304
Closed Access | Times Cited: 67
Lipid Nanoparticle (LNP) Delivery Carrier-Assisted Targeted Controlled Release mRNA Vaccines in Tumor Immunity
Liusheng Wu, Xiaoqiang Li, Xinye Qian, et al.
Vaccines (2024) Vol. 12, Iss. 2, pp. 186-186
Open Access | Times Cited: 53
Design of experiments in the optimization of nanoparticle-based drug delivery systems
Riccardo Rampado, Dan Peer
Journal of Controlled Release (2023) Vol. 358, pp. 398-419
Closed Access | Times Cited: 52
Lipid Nanoparticles Optimized for Targeting and Release of Nucleic Acid
Yaru Jia, Xiu‐Guang Wang, Luwei Li, et al.
Advanced Materials (2023) Vol. 36, Iss. 4
Closed Access | Times Cited: 47
Recent advances in nanoparticulate RNA delivery systems
Jacob Witten, Yizong Hu, Róbert Langer, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 11
Open Access | Times Cited: 36
Morphological Characterization of Self-Amplifying mRNA Lipid Nanoparticles
Jacob L. Thelen, Wellington Leite, Volker S. Urban, et al.
ACS Nano (2024) Vol. 18, Iss. 2, pp. 1464-1476
Closed Access | Times Cited: 19
Size exclusion chromatography of biopharmaceutical products: From current practices for proteins to emerging trends for viral vectors, nucleic acids and lipid nanoparticles
Valentina D’Atri, Mateusz Imiołek, Colette F. Quinn, et al.
Journal of Chromatography A (2024) Vol. 1722, pp. 464862-464862
Open Access | Times Cited: 19
Quality assessment of LNP-RNA therapeutics with orthogonal analytical techniques
Jérémie Parot, Dóra Méhn, Hanna Jankevics, et al.
Journal of Controlled Release (2024) Vol. 367, pp. 385-401
Open Access | Times Cited: 18
Lipid Nanoparticle Technologies for Nucleic Acid Delivery: A Nanoarchitectonics Perspective
Abdul Rahim Ferhan, Soo-Hyun Park, Hyeonjin Park, et al.
Advanced Functional Materials (2022) Vol. 32, Iss. 37
Closed Access | Times Cited: 63
Recent Advances in Lipid Nanoparticles for Delivery of mRNA
Lei Yang, Liming Gong, Ping Wang, et al.
Pharmaceutics (2022) Vol. 14, Iss. 12, pp. 2682-2682
Open Access | Times Cited: 63
The role of nanoparticle format and route of administration on self-amplifying mRNA vaccine potency
Giulia Anderluzzi, Gustavo Lou, Stuart Woods, et al.
Journal of Controlled Release (2021) Vol. 342, pp. 388-399
Open Access | Times Cited: 57
Comparison of DLin-MC3-DMA and ALC-0315 for siRNA Delivery to Hepatocytes and Hepatic Stellate Cells
Francesca Ferraresso, Amy W. Strilchuk, Lih Jiin Juang, et al.
Molecular Pharmaceutics (2022) Vol. 19, Iss. 7, pp. 2175-2182
Open Access | Times Cited: 57
Page 1 - Next Page

Scroll to top